-
Verastem Oncology Announces Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in Frontline Metastatic Pancreatic Ductal Adenocarcinoma
22 May 2025 21:29 GMT
… patients with metastatic pancreatic ductal adenocarcinoma (PDAC). As of April 25 … G12C mutant non-small cell lung cancer (RAMP 203; NCT05074810). Avutometinib and …
-
Historic p87 Is Promising for Earlier All-Type Lung Cancer Diagnoses
20 May 2025 18:21 GMT
… especially concerning because lung cancer often has poor … been diagnosed with lung cancer. Stool and colonic … lung cancers) and higher, with 56% for SCC and 25% for adenocarcinoma … test could help direct lung cancer screening,” the researchers emphasized …
-
Women Veterans Less Adherent with Lung Cancer Screening Follow-up
20 May 2025 18:21 GMT
… Task Force guidelines for lung cancer screening (LCS) called … women than men. In lung cancer in general, a shift … that increasing rates of adenocarcinoma in women, particularly those … Association Between Sex and Lung Cancer Screening Adherence to Follow- …
-
Verastem Oncology announces positive results from RAMP 205 evaluating avutometinib plus defactinib in combo with standard─of─care chemotherapy in frontline metastatic PDAC
24 May 2025 13:22 GMT
… patients with metastatic pancreatic ductal adenocarcinoma (PDAC). As of April 25 … G12C mutant non-small cell lung cancer (RAMP 203; NCT05074810). Avutometinib and …
-
Quercetin and Nano-Derivatives: Potential and Challenges in Cancer Therapy
24 May 2025 12:50 GMT
… target EMT.84 In lung cancer, QUE inhibits metastasis … translocation of β-catenin in lung cancer cell line. Nutr Cancer … Quercetin suppresses pancreatic ductal adenocarcinoma progression via inhibition of … in non-small cell lung cancer. Biomed Pharmacother. 2023 …
-
Geriatric Nutritional Risk Index (GNRI) and Prognostic Nutritional Index (PNI) Before Treatment as the Predictive Indicators for Bone Metastasis in Prostate Cancer Patients
24 May 2025 12:50 GMT
… in men worldwide after lung cancer.2 Both the … , et al. Advanced lung cancer inflammation index combined with geriatric … survival of localised gastric adenocarcinoma after curative resection. J … for non-small cell lung cancer patients with bone metastasis. …
-
Expression and Diagnostic Value of Nrf2 and p62 in Cervical Squamous Cell Carcinoma and Intraepithelial Lesions
24 May 2025 12:50 GMT
… squamous cells, and adenocarcinoma, which arises from … carcinoma and pancreatic ductal adenocarcinoma, thereby inducing tumorigenesis … various cancers, such as lung cancer, liver cancer, kidney … SQSTM1 expression in gastric adenocarcinoma. Anticancer Res. 2019 …
-
Functionalized Boron Carbide Nanoparticles as Active Boron Delivery Agents Dedicated to Boron Neutron Capture Therapy
24 May 2025 00:50 GMT
… selected: PC-3 prostate adenocarcinoma, T98G glioblastoma multiforme, … lung adenocarcinoma cells. Additionally, in mice with lung cancer and … 106 cells to A549 lung cancer cells.35
The obtained … Capture Therapy in the lung cancer treatment. Nanomedicine. 2015 …
-
ASCO 2025: The Presentations That May Shift the Cancer Care Paradigm
23 May 2025 18:30 GMT
… untreated metastatic pancreatic ductal adenocarcinoma (mPDAC).
Presentation: May … with metastatic pancreatic ductal adenocarcinoma (PDAC).
In May … include non–small cell lung cancer (NSCLC) and melanoma … metastatic non-small cell lung cancer (NSCLC) or cutaneous …
-
Foundation Medicine Expands Immunohistochemistry (IHC) Testing Portfolio to Include MET IHC Testing
23 May 2025 18:43 GMT
… non-squamous non-small cell lung cancer (NSCLC).
Using antibodies to detect … with gastric or gastroesophageal junction adenocarcinoma whose tumors are claudin (CLDN … -positive gastric/gastroesophageal junction adenocarcinoma, head and neck squamous cell …